Tyler Berzin, MD, performed the procedure, according to a LinkedIn post by Terri Reese-Steinek, Medtronic’s executive capital sales manager.
The FDA in April granted de novo clearance for the device, which is Medtronic’s first AI system for colonoscopies.
The device uses AI to identify colorectal polyps and is compatible with any colonoscopy video.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.